Aminoacyl tRNA synthetase 3D structures
From Proteopedia
(Difference between revisions)
Line 268: | Line 268: | ||
* ''Met-RS + tRNA'' | * ''Met-RS + tRNA'' | ||
- | |||
**[[2csx]] – AaMetRS + Met-tRNA<br /> | **[[2csx]] – AaMetRS + Met-tRNA<br /> | ||
Line 408: | Line 407: | ||
**[[1ivs]] – TtValRS + Val-SA + Val-tRNA<br /> | **[[1ivs]] – TtValRS + Val-SA + Val-tRNA<br /> | ||
**[[1gax]] - TtValRS + Val-adenylate analog + Val-tRNA<br /> | **[[1gax]] - TtValRS + Val-adenylate analog + Val-tRNA<br /> | ||
- | |||
*Class II aaRS | *Class II aaRS | ||
Line 417: | Line 415: | ||
**[[4xeo]] - hAlaRS catalytic domain (mutant)<br /> | **[[4xeo]] - hAlaRS catalytic domain (mutant)<br /> | ||
**[[5t5s]], [[5t76]] - hAlaRS residues 757-965<br /> | **[[5t5s]], [[5t76]] - hAlaRS residues 757-965<br /> | ||
+ | **[[6nlq]], [[6nly]], [[6now]] - hAlaRS C-terminal<br /> | ||
**[[3g98]] – AaAlaRS residues 758-867<br /> | **[[3g98]] – AaAlaRS residues 758-867<br /> | ||
**[[1riq]] - AaAlaRS catalytic fragment<br /> | **[[1riq]] - AaAlaRS catalytic fragment<br /> | ||
Line 451: | Line 450: | ||
**[[5gro]] – HpAspRS N terminal<br /> | **[[5gro]] – HpAspRS N terminal<br /> | ||
**[[4rmf]] – MsAspRS <br /> | **[[4rmf]] – MsAspRS <br /> | ||
+ | **[[6wom]] – ElAspRS <br /> | ||
* ''Asp-RS + small substrates or analogs'' | * ''Asp-RS + small substrates or analogs'' | ||
Line 466: | Line 466: | ||
**[[5y6l]] - hAspRS + MetRS + Glu/ProRS + P18 + P38 <br /> | **[[5y6l]] - hAspRS + MetRS + Glu/ProRS + P18 + P38 <br /> | ||
+ | **[[6iy6]] - hAspRS + AIMP2 + Glu/ProRS residues 1-157<br /> | ||
**[[1il2]], [[1c0a]] – EcAspRS + Asp-tRNA + Asp-adenylate<br /> | **[[1il2]], [[1c0a]] – EcAspRS + Asp-tRNA + Asp-adenylate<br /> | ||
+ | **[[7ap4]] – TtAspRS + inhibitor<br /> | ||
+ | **[[6hhv]], [[6hhw]] – TtAspRS + Asp-SU<br /> | ||
+ | **[[6hhx]] – TtAspRS + Asp-SC<br /> | ||
+ | **[[6sjc]] – TtAspRS + Asp-SA<br /> | ||
**[[4wj4]] – PaAspRS + Asn-tRNA + Asp<br /> | **[[4wj4]] – PaAspRS + Asn-tRNA + Asp<br /> | ||
**[[4wj3]] – PaAspRS + Asn-tRNA + amidotransferase<br /> | **[[4wj3]] – PaAspRS + Asn-tRNA + amidotransferase<br /> | ||
Line 476: | Line 481: | ||
**[[1x56]] - PhAsnRS<br /> | **[[1x56]] - PhAsnRS<br /> | ||
**[[2kqr]] – BmAsnRS N-terminal – NMR – ''Brugia malayi''<br /> | **[[2kqr]] – BmAsnRS N-terminal – NMR – ''Brugia malayi''<br /> | ||
+ | **[[6pqh]] – ElAsnRS<br /> | ||
* ''Asn-RS + small substrates or analogs'' | * ''Asn-RS + small substrates or analogs'' | ||
Line 513: | Line 519: | ||
*'''His-RS''' | *'''His-RS''' | ||
- | **[[4x5o]], [[4g84]], [[4g85]] - hHisRS <br /> | + | **[[4x5o]], [[4g84]], [[4g85]], [[6o76]] - hHisRS <br /> |
**[[5w6m]] - hHisRS (mutant)<br /> | **[[5w6m]] - hHisRS (mutant)<br /> | ||
**[[1x59, [[2lw7]] – hHisRS WHEP-TRS domain - NMR<br /> | **[[1x59, [[2lw7]] – hHisRS WHEP-TRS domain - NMR<br /> | ||
Line 546: | Line 552: | ||
**[[5mgw]], [[5mgh]], [[5mgu]], [[5mgv]] – hPheRS (mutant)<br /> | **[[5mgw]], [[5mgh]], [[5mgu]], [[5mgv]] – hPheRS (mutant)<br /> | ||
**[[1pys]] – TtPheRS<br /> | **[[1pys]] – TtPheRS<br /> | ||
- | **[[2cxi]] – PhPheRS chain N-terminal<br /> | + | **[[2cxi]] – PhPheRS β chain N-terminal<br /> |
- | **[[3ica]] – PheRS chain – ''Porphyromonas gingivalis''<br /> | + | **[[3ica]] – PheRS β chain – ''Porphyromonas gingivalis''<br /> |
- | **[[4p71]] – PaPheRS | + | **[[4p71]] – PaPheRS α+β chain<br /> |
- | **[[3ig2]] – PheRS chain – ''Bacterioides fragilis''<br /> | + | **[[3ig2]] – PheRS β chain – ''Bacterioides fragilis''<br /> |
+ | **[[7daw]] – MtPheRS + α+β chains <br /> | ||
+ | **[[6p24]] – EcPheRS + α+β chains <br /> | ||
* ''Phe-RS + small substrates or analogs'' | * ''Phe-RS + small substrates or analogs'' | ||
Line 555: | Line 563: | ||
**[[3teg]] – hPheRS + L-DOPA<br /> | **[[3teg]] – hPheRS + L-DOPA<br /> | ||
**[[3pco]] – EcPheRS + phenylalanine+ AMP <br /> | **[[3pco]] – EcPheRS + phenylalanine+ AMP <br /> | ||
- | **[[3hfz]], [[2amc]] – TtPheRS + chains + Tyr<br /> | + | **[[6oz5]], [[6p26]] – EcPheRS α+β chains + inhibitor<br /> |
- | **[[2akw]], [[1b70]] - TtPheRS + chains + Phe<br /> | + | **[[3hfz]], [[2amc]] – TtPheRS α+β chains + Tyr<br /> |
- | **[[4tva]] - TtPheRS + chains + Phe + puromycin<br /> | + | **[[2akw]], [[1b70]] - TtPheRS α+β chains + Phe<br /> |
- | **[[3teh]] - TtPheRS + chains + L-DOPA<br /> | + | **[[4tva]] - TtPheRS α+β chains + Phe + puromycin<br /> |
- | **[[1jjc]], [[1b7y]] - TtPheRS + chains + Phe-adenylate<br /> | + | **[[3teh]] - TtPheRS α+β chains + L-DOPA<br /> |
- | **[[2aly]] - TtPheRS + chains + Phe-SA<br /> | + | **[[1jjc]], [[1b7y]] - TtPheRS α+β chains + Phe-adenylate<br /> |
- | **[[2rhq]], [[2rhs]] – PheRS + chains (mutant) + inhibitor – ''Staphylococcus haemolyticus''<br /> | + | **[[2aly]] - TtPheRS α+β chains + Phe-SA<br /> |
- | **[[4p72]], [[4p73]], [[4p74]], [[4p75]] – PaPheRS + chains + inhibitor<br /> | + | **[[2rhq]], [[2rhs]] – PheRS α+β+ chains (mutant) + inhibitor – ''Staphylococcus haemolyticus''<br /> |
+ | **[[4p72]], [[4p73]], [[4p74]], [[4p75]] – PaPheRS α+β chains + inhibitor<br /> | ||
+ | **[[7db7]], [[7db8]] – MtPheRS α+β chains + inhibitor<br /> | ||
+ | **[[6p8t]] – AbPheRS α+β chains + inhibitor<br /> | ||
* ''Phe-RS + tRNA'' | * ''Phe-RS + tRNA'' | ||
**[[3tup]] – hPheRS + Phe-tRNA<br /> | **[[3tup]] – hPheRS + Phe-tRNA<br /> | ||
- | **[[1eiy]] - TtPheRS + chains + Phe-tRNA<br /> | + | **[[1eiy]] - TtPheRS α+β chains + Phe-tRNA<br /> |
- | **[[2iy5]] - TtPheRS + chains + Phe-ol + Phe-tRNA<br /> | + | **[[2iy5]] - TtPheRS α+β chains + Phe-ol + Phe-tRNA<br /> |
*'''Pro-RS''' | *'''Pro-RS''' | ||
Line 576: | Line 587: | ||
**[[1nj2]] - MtProRS –'' Methanothermobacter thermautotrophicus''<br /> | **[[1nj2]] - MtProRS –'' Methanothermobacter thermautotrophicus''<br /> | ||
**[[1nj8]] – MjProRS<br /> | **[[1nj8]] – MjProRS<br /> | ||
- | **[[5xif]] – TgProRS residues 334-830 <br /> | + | **[[5xif]], [[6aa0]] – TgProRS residues 334-830 <br /> |
**[[5ucm]] – PaProRS <br /> | **[[5ucm]] – PaProRS <br /> | ||
**[[4twa]], [[4ncx]] – PfProRS residues 249-746 <br /> | **[[4twa]], [[4ncx]] – PfProRS residues 249-746 <br /> | ||
Line 599: | Line 610: | ||
**[[5f9y]] – CpProRS residues 186-688 + proline + AMP<br /> | **[[5f9y]] – CpProRS residues 186-688 + proline + AMP<br /> | ||
**[[5xio]] – CpProRS residues 225-719 + halofuginone + ANP <br /> | **[[5xio]] – CpProRS residues 225-719 + halofuginone + ANP <br /> | ||
- | **[[6nab]] - | + | **[[5znj]] – SaProRS + halofuginone + ANP <br /> |
+ | **[[5znk]] – SaProRS + inhibitor + ANP <br /> | ||
+ | **[[6nab]] - NfProRS + Pro + AMP – ''Naegleria fowleri''<br /> | ||
+ | **[[6uyh]] – NfProRS + halofuginone + ANP <br /> | ||
**[[5xiq]] – TgProRS residues 334-830 + halofuginone + ANP <br /> | **[[5xiq]] – TgProRS residues 334-830 + halofuginone + ANP <br /> | ||
- | **[[5xik]] – TgProRS residues 334-830 + febrifugine derivative + ANP <br /> | + | **[[5xik]], [[6a88]] – TgProRS residues 334-830 + febrifugine derivative + ANP <br /> |
**[[5xig]], [[5xih]], [[5xij]] – TgProRS residues 334-830 + inhibitor + ANP <br /> | **[[5xig]], [[5xih]], [[5xij]] – TgProRS residues 334-830 + inhibitor + ANP <br /> | ||
**[[5xii]] – TgProRS residues 334-830 (mutant) + inhibitor + ANP <br /> | **[[5xii]] – TgProRS residues 334-830 (mutant) + inhibitor + ANP <br /> | ||
**[[4ydq]], [[4q15]], [[4olf]] – PfProRS residues 254-746 + halofuginone + AMPPNP <br /> | **[[4ydq]], [[4q15]], [[4olf]] – PfProRS residues 254-746 + halofuginone + AMPPNP <br /> | ||
+ | **[[6t7k]] – PfProRS residues 254-746 + inhibitor <br /> | ||
*'''Bifunctional RS''' (bifunctional glutamate/proline tRNA ligase) | *'''Bifunctional RS''' (bifunctional glutamate/proline tRNA ligase) | ||
- | **[[4hvc]] – | + | **[[4hvc]] – hGlu/ProRS residues 1003-1513 + halofunginone + ATP analog<br /> |
- | **[[5v58]] – | + | **[[5v58]] – hGlu/ProRS residues 1003-1513 + AZ-SA<br /> |
- | **[[5vad]] – | + | **[[5vad]] – hGlu/ProRS residues 1003-1513 + inhibitor<br /> |
- | **[[5a1n]], [[5a34]], [[5a5h]] – | + | **[[5a1n]], [[5a34]], [[5a5h]] – hGlu/ProRS GST-like domain + EPRS-AIMP2<br /> |
+ | **[[1fyj]] – hGlu/ProRS 677-733 – NMR<br />, [[6 | ||
*'''Pyrrolysyl-RS'''; domains – RNA-binding 1-101; catalytic 188-454 | *'''Pyrrolysyl-RS'''; domains – RNA-binding 1-101; catalytic 188-454 | ||
Line 618: | Line 634: | ||
**[[3vqw]], [[3vqx]], [[4cs2]] - MmPylRS catalytic domain (mutant)<br /> | **[[3vqw]], [[3vqx]], [[4cs2]] - MmPylRS catalytic domain (mutant)<br /> | ||
**[[3dsq]] – DhPylRS<br /> | **[[3dsq]] – DhPylRS<br /> | ||
- | **[[6ezd]] – PylRS – ''Methanomethylophilus alvus''<br /> | + | **[[6ezd]], [[6jp2]] – PylRS – ''Methanomethylophilus alvus''<br /> |
*''Pyrrolysyl-RS binary complex'' | *''Pyrrolysyl-RS binary complex'' | ||
Line 643: | Line 659: | ||
**[[4tqd]] - MmPylRS catalytic domain + iodo-Phe + ATP <br /> | **[[4tqd]] - MmPylRS catalytic domain + iodo-Phe + ATP <br /> | ||
**[[4tqf]], [[4zib]] - MmPylRS catalytic domain + bromothienylo-Ala + ATP <br /> | **[[4tqf]], [[4zib]] - MmPylRS catalytic domain + bromothienylo-Ala + ATP <br /> | ||
+ | **[[6ly3]], [[6ly6]], [[6lyb]] - MmPylRS catalytic domain (mutant) + Ala derivative+ ANP <br /> | ||
+ | **[[6ly7]], [[6lya]] - MmPylRS catalytic domain (mutant) + Trp derivative + ANP <br /> | ||
**[[2zin]] - MmPylRS catalytic domain + butoxycarbonyl lysine + ATP analog <br /> | **[[2zin]] - MmPylRS catalytic domain + butoxycarbonyl lysine + ATP analog <br /> | ||
+ | **[[6aac]], [[6aad]], [[6aao]], [[6aap]], [[6aaz]], [[6ab0]], [[6ab1]], [[6ab2]], [[6ab8]], [[6abk]], [[6abl]], [[6abm]], [[6aan]], [[6anq]] - MmPylRS catalytic domain + azanyl derivative + ATP <br /> | ||
*'''Ser-RS''' | *'''Ser-RS''' | ||
**[[3vbb]] - hSerRS <br /> | **[[3vbb]] - hSerRS <br /> | ||
+ | **[[6gir]] - SerRS – ''Arabidopsis thaliana'' <br /> | ||
**[[3lsq]] – TbSerRS <br /> | **[[3lsq]] – TbSerRS <br /> | ||
**[[1sry]] - TtSerRS<br /> | **[[1sry]] - TtSerRS<br /> | ||
Line 655: | Line 675: | ||
**[[2dq3]] – AaSerRS<br /> | **[[2dq3]] – AaSerRS<br /> | ||
**[[2du7]] – MjSerRS<br /> | **[[2du7]] – MjSerRS<br /> | ||
- | **[[2odr]] – | + | **[[2odr]] – MemSerRS – ''Methanococcus maripaludis''<br /> |
**[[2cim]] – MbSerRS – ''Methanosarcina barkeri''<br /> | **[[2cim]] – MbSerRS – ''Methanosarcina barkeri''<br /> | ||
- | **[[1wle]] – SerRS – bovine<br /> | ||
- | **[[6gir]] - SerRS – ''Arabidopsis thaliana'' <br /> | ||
**[[3qne]], [[3qo5]], [[3qo7]], [[3qo8]] - CaSerRS <br /> | **[[3qne]], [[3qo5]], [[3qo7]], [[3qo8]] - CaSerRS <br /> | ||
* ''Ser-RS + small substrates or analogs'' | * ''Ser-RS + small substrates or analogs'' | ||
**[[4l87]] - hSerRS + Ser-SA<br /> | **[[4l87]] - hSerRS + Ser-SA<br /> | ||
+ | **[[1wle]] – bSerRS + Ser-adenylate - bovine<br /> | ||
**[[2zr2]] – PhSerRS + ATP<br /> | **[[2zr2]] – PhSerRS + ATP<br /> | ||
**[[2dq0]] – PhSerRS + Ser-SA<br /> | **[[2dq0]] – PhSerRS + Ser-SA<br /> | ||
Line 669: | Line 688: | ||
**[[2cja]] – MbSerRS + ATP<br /> | **[[2cja]] – MbSerRS + ATP<br /> | ||
**[[1ses]], [[1set]] – TtSerRS + Ser-adenylate analog<br /> | **[[1ses]], [[1set]] – TtSerRS + Ser-adenylate analog<br /> | ||
+ | **[[6r1m]], [[6r1n]] – SaSerRS + Ser-SA<br /> | ||
+ | **[[6hdz]], [[6he1]], [[6hhy]], [[6hi0]] – PaSerRS + Ser-SU<br /> | ||
+ | **[[6he3]], [[6hhz]] – PaSerRS + Ser-SC<br /> | ||
+ | **[[6r1o]] – EcSerRS + Ser-SA<br /> | ||
+ | **[[6h9x]] – KpSerRS + Ser-SA<br /> | ||
+ | **[[7ap1]] – KpSerRS + inhibitor<br /> | ||
+ | **[[6ote]] – CpSerRS + Ser-SA<br /> | ||
+ | **[[6x94]] – MmSerRS + Ser-SA<br /> | ||
* ''Ser-RS + tRNA'' | * ''Ser-RS + tRNA'' | ||
Line 681: | Line 708: | ||
**[[2du3]], [[5x6c]] – AfPSerRS + Cys-tRNA + phosphoserine<br /> | **[[2du3]], [[5x6c]] – AfPSerRS + Cys-tRNA + phosphoserine<br /> | ||
**[[2du5]], [[2du6]] - AfPSerRS (mutant) + Cys-tRNA + phosphoserine<br /> | **[[2du5]], [[2du6]] - AfPSerRS (mutant) + Cys-tRNA + phosphoserine<br /> | ||
+ | **[[2odr]] - MemPSerRS <br /> | ||
*'''Thr-RS''' | *'''Thr-RS''' | ||
Line 686: | Line 714: | ||
**[[1wwt]] – hThrRS TGS domain – NMR<br /> | **[[1wwt]] – hThrRS TGS domain – NMR<br /> | ||
**[[3ugq]], [[3ugt]] - yThrRS <br /> | **[[3ugq]], [[3ugt]] - yThrRS <br /> | ||
- | **[[1y2q]] - | + | **[[1y2q]] - PabThrRS editing domain 1-143<br /> |
- | **[[1tje]] - EcThrRS editing domain<br /> | + | **[[1tje]] - EcThrRS editing domain 1-224<br /> |
+ | **[[7l3o]] - CpThrRS <br /> | ||
* ''Thr-RS + small substrates or analogs'' | * ''Thr-RS + small substrates or analogs'' | ||
- | **[[4p3n]] - hThrRS editing domain + borrelidin<br /> | + | **[[4p3n]] - hThrRS editing domain 322-723 + borrelidin<br /> |
**[[4hws]] - hThrRS editing domain + inhibitor<br /> | **[[4hws]] - hThrRS editing domain + inhibitor<br /> | ||
**[[3uh0]] - yThrRS editing domain + Thr-SA<br /> | **[[3uh0]] - yThrRS editing domain + Thr-SA<br /> | ||
**[[4eo4]] - yThrRS editing domain + Ser-SA<br /> | **[[4eo4]] - yThrRS editing domain + Ser-SA<br /> | ||
- | **[[3pd2]], [[3pd3]], [[3pd4]], [[3pd5]] – | + | **[[3pd2]], [[3pd3]], [[3pd4]], [[3pd5]] – PabThrRS editing domain + aa-aminoadenosine<br /> |
- | **[[2hkz]] – | + | **[[2hkz]] – PabThrRS editing domain + Ser<br /> |
- | **[[2hl0]], [[2hl1]] - | + | **[[2hl0]], [[2hl1]] - PabThrRS editing domain + Ser-adenylate<br /> |
- | **[[2hl2]] - | + | **[[2hl2]] - PabThrRS editing domain + Ser-SA<br /> |
**[[1tke]] - EcThrRS editing domain + Ser<br /> | **[[1tke]] - EcThrRS editing domain + Ser<br /> | ||
**[[1tkg]] - EcThrRS editing domain + Ser-SA<br /> | **[[1tkg]] - EcThrRS editing domain + Ser-SA<br /> | ||
Line 712: | Line 741: | ||
**[[4rrf]] - MjThrRS editing domain + Ser<br /> | **[[4rrf]] - MjThrRS editing domain + Ser<br /> | ||
**[[4rrg]] - MjThrRS editing domain + Thr<br /> | **[[4rrg]] - MjThrRS editing domain + Thr<br /> | ||
+ | **[[6l2q]] - ThrRS 222-622 + inhibitor – ''Salmonella enterica''<br /> | ||
* ''Thr-RS + tRNA'' | * ''Thr-RS + tRNA'' | ||
Line 719: | Line 749: | ||
**[[1kog]] – EcThrRS catalytic and anticodon-binding domains + mRNA<br /> | **[[1kog]] – EcThrRS catalytic and anticodon-binding domains + mRNA<br /> | ||
- | *'''Multifunctional RS''' | ||
- | |||
- | **[[1fyj]] – hRS – NMR<br /> | ||
}} | }} | ||
[[Category: Topic Page]] | [[Category: Topic Page]] |
Revision as of 09:42, 16 March 2021
3D Structures of Aminoacyl tRNA Synthetase
Updated on 16-March-2021
{{#tree:id=OrganizedByTopic|openlevels=0|
- Class I aaRS
- Arg-RS
- Arg-RS + small substrates or analogs
- Arg-RS + tRNA
- Arg-RS ternary complex
- Cys-RS
- Gln-RS
- 4ye6 – hGlnRS
- 4ye8, 4ye9 – hGlnRS (mutant)
- 4h3s – yGlnRS
- 3tl4 – yGlnRS tRNA-binding domain
- 1nyl – EcGlnRS
- 5zdo – TtGlnRS
- 5zdk, 5zdl – TtGlnRS + ATP
- 2gls, 1lgr – StGlnRS – Salmonella typhimurium
- 5bnz – PaGlnRS – Pseudomonas aeruginosa
- 4p2b – TgGlnRS catalytic domain – Toxoplasma gondii
- 2lgs – StGlnRS + Glu<br /
- 1qrs, 1qrt, 1qru - EcGlnRS (mutant) + Gln-tRNA
- 1gtr, 1gts, 1gsg - EcGlnRS + Gln-tRNA
- 4ye6 – hGlnRS
- Gln-RS ternary complex
- Glu-RS
- 2hra – yGluRS N-terminal
- 1gln – TtGluRS
- 2o5r - TmGluRS
- 3aii – GluRS – Methanothermobacter thermautotrophicus
- 2ja2, 3pny – MtGluRS – Mycobacterium tuberculosis
- 3pnv - MtGluRS (mutant)
- 4a91 – EcGluRS
- 2hz7 – DrGluRS – Deinococcus radiodurans
- 6b1p - HpGluRS – Helicobacter pylori
- 6b1z - EaGluRS – Elizabethkingia anophelis
- 5tgt – PaGluRS
- 5h4v – GluRS – Xanthomonas oryzae
- 7k86 – SmGluRS – Stenotrophomonas maltophilia
- 2hra – yGluRS N-terminal
- Glu-RS + small substrates or analogs
- 3afh - TmGluRS + Glu-AMP analog
- 2rd2, 2re8 – EcGluRS (mutant) + Glu-SA
- 2cuz – TtGluRS + Glu
- 1j09 - TtGluRS + Glu + ATP
- 1n75 - TtGluRS + ATP
- 2cfo - GluRS residues 2-485 + Glu – Synechococcus elongatus
- 6brl - GluRS + Glu - Elizabethkingia meningoseptica
- 4grl - BbGluRS + Glu
- 4g6z - BtGluRS + Glu – Burkholderia thailandensis
- 3afh - TmGluRS + Glu-AMP analog
- Glu-RS ternary complex
- 5bmu – hGluRS GST-like domain + EPRS-AIMP3
- 2hrk, 2hsm - yGluRS N-terminal + GU4 nucleic-binding protein 1
- 3akz, 3al0 – TmGluRS + tRNA + Glu-AMP analog – Thermotoga maritima
- 1o0b, 1o0c - EcGluRS + Glu-tRNA + Glu + AMP
- 2cv0, 1n77 - TtGluRS + Glu + Glu-tRNA
- 1n78 - TtGluRS + Glu-ol + Glu-tRNA
- 2cv1 - TtGluRS + Glu-ol + ATP + Glu-tRNA
- 2cv2 - TtGluRS + Glu-SA + Glu-tRNA
- 5bmu – hGluRS GST-like domain + EPRS-AIMP3
- Ile-RS
- Ile-RS + small substrates or analogs
- Ile-RS ternary complex
- Leu-RS
- 2wfd – hLeuRS editing domain 260-509
- 3o0a, 3pz0 – AaLeuRS hydrolytic domain – Aquifex aeolicus
- 3pz5 – AaLeuRS hydrolytic domain (mutant)
- 2wfe - CaLeuRS editing domain – Candida albicans
- 5agh - CaLeuRS editing domain (mutant)
- 2ajg - EcLeuRS editing domain
- 1wkb – PhLeuRS residues 1-810
- 5fon - CmLeuRS editing domain – Cryptosporidium muris
- 5foc - PfLeuRS editing domain
- 5fod - PfLeuRS editing domain (mutant)
- 5fof - LeuRS editing domain – Plasmodium knowlesi
- 4k48 - SpLeuRS editing domain (mutant) – Streptococcus pneumoniae
- 3pz6 - LeuRS editing domain (mutant) – Giardia intestinalis
- 2wfd – hLeuRS editing domain 260-509
- Leu-RS + small substrates or analogs
- 6kqy - hLeuRS + Leu
- 7d5c - yLeuRS + inhibitor
- 6ykk, 6ykl, 6ykn, 6yko, 6ykq, 6yks, 6ykt, 6yku, 6ykv, 6kyw, 6ykx, 7a0p, 7ap2 - NgLeuRS (mutant) + inhibitor
- 6q89, 6q8a, 6q8b, 6q8c - NgLeuRS (mutant) + intermediate analog
- 2wfg - CaLeuRS editing domain + benzoxaborole-AMP
- 1h3n - TtLeuRS + Leu-SA
- 1obc, 1obh – TtLeuRS + substrate analog
- 2ajh, 2aji - EcLeuRS editing domain + aa
- 4aq7 - EcLeuRS editing domain + Leu-adenylate analog
- 4cqn - EcLeuRS editing domain + Ile-adenylate analog
- 5fog - CmLeuRS editing domain + norvaline
- 5fol - CmLeuRS editing domain + Ile
- 5fom - CmLeuRS editing domain + inhibitor
- 5agj - CaLeuRS editing domain + AMP derivative
- 5agi - CaLeuRS editing domain (mutant) + AMP derivative
- 5agr, 5ags, 5agt - MtLeuRS editing domain + inhibitor
- 7bzj - SpLeuRS + inhibitor
- 4k47 - SpLeuRS editing domain (mutant) + benzoxaborole-AMP
- 3ziu - LeuRS editing domain + Leu-SA – Mycoplasma mobile
- 6kqy - hLeuRS + Leu
- Leu-RS ternary complex
- 6kie, 6kr7 - hLeuRS + Leu-SA + Leu
- 6lpf, 6lr6 - hLeuRS + Leu-SA + adenosine derivative
- 6kid - hLeuRS + ATP + Leu
- 4arc - EcLeuRS + Leu-tRNA + Leu
- 5omw - EcLeuRS + Leu-tRNA + Leu-adenylate analog
- 4ari, 4as1, 3zjt, 3zju, 3zjv - EcLeuRS + Leu-tRNA + benzoxaborole
- 3zgz - EcLeuRS + Leu-tRNA + inhibitor
- 5onh - EcLeuRS + Leu-tRNA + Leu-adenylate analog + norvaline
- 5on2 - EcLeuRS (mutant) + Leu-tRNA + Leu-adenylate analog + norvaline
- 5on3 - EcLeuRS (mutant) + Leu-tRNA + Leu-adenylate analog + Leu
- 2v0g - TtLeuRS + Leu-tRNA + benzoxaborole-AMP
- 2bte, 2byt - TtLeuRS + Leu-tRNA + Leu
- 2v0c – TtLeuRS + Leu-SA + benzoxaborole-AMP
- 6kie, 6kr7 - hLeuRS + Leu-SA + Leu
- Lys-RS
- Lys-RS binary complexes
- 6chd - hLysRS + Lys-adenylate derivative
- 4up7 - EhLysRS + Lys-adenylate
- 4up9 - EhLysRS + ATP
- 4upa - EhLysRS (mutant) + AMPPNP
- 3e9h, 3e9i]] – BsLysRS + Lys-SA - Bacillus stearothermophilus
- 3a74 - BsLysRS + diadenosine tetraphosphate
- 5zh2, 5zh3, 5zh4, 5zh5, 4pg3, 6hcv - PfLysRS + inhibitor
- 4ycv - PfLysRS + cladosporin
- 5vl1 - MuLysRS + Lys – Mycobacterium ulcerans
- 5hgq - LysRS + cladosporin – eye worm
- 1bbu, 1e1o, 1lyl – EcLysRS + Lys
- 1e1t - EcLysRS + Lys-adenylate
- 6c86 - CpLysRS + Lys-adenylate derivative - Cryptosporidium parvum
- 5eln - CpLysRS + Lys
- 4ex5 - BtLysRS + Lys
- 6wbd - SmLysRS + Lys
- 6chd - hLysRS + Lys-adenylate derivative
- Lys-RS ternary complexes
- 6ild, 4dpg - hLysRS + P38 + AIMP2
- 4ycu - hLysRS + P38 + cladosporin
- 4ycw - hLysRS (mutant) + P38 + cladosporin
- 1e22 - EcLysRS + Lys + AMPPCP
- 1e24 - EcLysRS + Lys + ATP
- 6nrz - CtLysRS + Lys + adenosine – Chlamydia trachomatis
- 6ns0, 6o3f - CtLysRS + Lys + cladosporin
- 6bni - CpLysRS + Lys + adenine
- 5elo - CpLysRS + Lys + cladosporin
- 6aqg - MuLysRS + Lys + cladosporin
- 6agt, 6ka6, 6kab, 6kbf, 6kcn, 6kct - PfLysRS + Lys + cladosporin derivative
- 7bt5 - PfLysRS + Lys + drug
- 6hcu, 6hcw - PfLysRS + Lys + inhibitor
- 6aqh - LysRS + Lys + cladosporin – Mycobacterium thermoresistibile
- 6ild, 4dpg - hLysRS + P38 + AIMP2
- Met-RS
- 5gl7 – hMetRS residues 221-834
- 2djv – hMetRS WHEP-TRS domain 835-900 – NMR
- 1med, 1mea – EcMetRS Zinc-binding domain - NMR
- 1qqt, 3h9c - EcMetRS residues 2-552
- 3h97, 6spp – EcMetRS residues 2-548 (mutant)
- 1a8h – TtMetRS
- 2d54, 2d5b – TtMetRS (mutant)
- 1woy – TtMetRS residues 1-500 (mutant)
- 1pyb – AaMetRS subunit
- 1rqg – PabMetRS – Pyrococcus abyssi
- 1mkh – PabMetRS C-terminal
- 5xgq – MtMetRS
- 5h34 – MetRS C-terminal – Nanoarchaeum equitans
- 2x1l - MsMetRS residues 2-515
- 5gl7 – hMetRS residues 221-834
- Met-RS + small substrates or analogs
- 5goy – hMetRS residues 221-834 + Met
- 3kfl – LmMetRS residues 206-747+ Met-adenylate - Leishmania major
- 2x1m - MsMetRS residues 2-515 + Met
- 1p7p, 1pfu, 1pfv, 1pfw - EcMetRS residues 2-548 + Met
- 1pfy - EcMetRS residues 1-551 + Met-SA
- 1f4l, 6spo - EcMetRS residues 1-551 + Met
- 6spq - EcMetRS (mutant) + Met
- 6spn - EcMetRS + beta-Met
- 6spr - EcMetRS (mutant) + beta-Met
- 1pg0 - EcMetRS residues 1-551 + Met-adenylate
- 1pg2 - EcMetRS residues 1-551 + Met + adenine
- 3h99 - EcMetRS residues 2-548 (mutant) + Met
- 3h9b - EcMetRS residues 2-548 (mutant) + azidonorleucine
- 4dlp - BmMetRS + SMet – Brucella melitensis
- 4py2 – BmMetRS + inhibitor
- 6ax8, 5xet – MtMetRS + Met-adenylate
- 3vu8 – TtMetRS + Met-adenylate analog
- 5urb - AbMetRS + Met – Acinetobacter baumannii
- 5k0s, 5k0t – MetRS + inhibitor – Brucella suis
- 4zt2, 4zt3, 4zt4, 4zt5, 4zt6, 4zt7, 4mvw, 4mvx, 4mvy, 4mw0, 4mw1, 4mw2, 4mw4, 4mw5, 4mw6, 4mw7, 4mw9, 4mwb, 4mwc, 4mwd, 4mwe - TbMetRS residues 237-773 (mutant) + inhibitor – Trypanosoma brucei
- 6cml, 6mes - TbMetRS residues 237-773 (mutant) + Met + inhibitor
- 4qrd, 4qre - SaMetRS + antibacterial
- 5goy – hMetRS residues 221-834 + Met
- Met-RS + tRNA
- Met-RS + protein
- Trp-RS
- 1o5t, 1ulh – hTrpRS catalytic fragment
- 5uji – hTrpRS catalytic fragment (mutant)
- 3kt0, 2ip1 – yTrpRS
- 1d2r - BsTrpRS
- 3prh – TrpRS (mutant) – Bacillus subtilis
- 3n9i – TrpRS – Yersinia pestis
- 3m5w – CjTrpRS – Campylobacter jejuni
- 3a04 – ApTrpRS – Aeropyrum pernix
- 3hzr – EhTrpRS
- 3i05 – TbTrpRS residues 3-389
- 3hv0 – CpTrpRS residues 206-593
- 3foc – GlTrpRS – Giardia lamblia
- 2el7 – TtTrpRS
- 2yy5 – TrpRS – Mycoplasma pneumoniae
- 2g36 – TmTrpRS
- 6mtk - EaTrpRS
- 5tev - NgTrpRS
- 4j76 - PfTrpRS
- 1o5t, 1ulh – hTrpRS catalytic fragment
- Trp-RS + small substrates or analogs
- 5ujj – hTrpRS + Trp-AMP
- 2quh – hTrpRS + Trp
- 2qui - hTrpRS + Trp-amide + ATP
- 2quj - hTrpRS + Trp-adenylate
- 2quk – hTrpRS + ATP
- 3kt3 – yTrpRS + Trp-adenylate
- 3kt6, 3kt8 – yTrpRS + Trp
- 3a05 – ApTrpRS + Trp
- 3jxe – PhTrpRS + Trp-adenylate
- 2ov4 – BsTrpRS + adenosine tetraphosphate
- 1i6k, 1i6l, 1i6m – BsTrpRS + Trp-adenylate
- 1yid, 2a4m – DrTrpRS + ATP
- 1yi8, 1yia– DrTrpRS + Trp
- 1maw, 1m83 - BsTrpRS + ATP
- 1mb2 - BsTrpRS + Trp
- 1bks – StTrpRS + pyridoxal phosphate
- 6ncr - CtTrpRS + Trp
- 5tew - NgTrpRS + Trp
- 4j75 - PfTrpRS + Trp-AMP
- 6dfu - TrpRS + Trp – Haemophilus influenzae
- 5ujj – hTrpRS + Trp-AMP
- Trp-RS ternary complex
- Tyr-RS
- 1n3l - hTyrRS
- 5thh, 5thl - hTyrRS (mutant)
- 1ntg - hTyrRS C-terminal
- 1r6t, 1r6u – yTyrRS (mutant)
- 1tya, 1tyb, 1tyc, 1tyd, 2ts1 – BsTyrRS
- 1jh3 – BsTyrRS C-terminal – NMR
- 3qe4, 3d6u, 3d6v, 2pxh, 2hgz, 1u7d, 5n5v, 5nsf – MjTyrRS – Methanocaldococcus jannaschii
- 1u7x, 4hjr, 4hk4, 5u36, 5l7p - MjTyrRS (mutant)
- 2jan – MtTyrRS
- 1y42, 4ojm - NcTyrRS – Neurospora crassa
- 2cya – ApTyrRS
- 6n0w - EaTyrRS
- 6byq - HpTyrRS
- 6bqz, 6bqy - AbTyrRS
- 5ihx - AnTyrRS – Aspergillus nidulans
- 2ktl - AnTyrRS C-terminal - NMR
- 5ijx - TyrRS – Coccidiodides posadasii
- 1n3l - hTyrRS
- Tyr-RS + small substrates or analogs
- 1q11 – hTyrRS residues 1-364 + Tyr-ol
- 2pid – hTyrRS residues 28-375 + Tyr-SA
- 4q93 - hTyrRS + resveratrol
- 4qbt - hTyrRS + Tyr
- 3zxi - hTyrRS + Tyr-adenylate analog
- 3ts1 – BsTyrRS + Tyr-adenylate intermediate
- 4ts1 – BsTyrRS + Tyr
- 3p0h, 3p0i]], 3p0j]] – LmTyrRS + inhibitor
- 3n2y – MjTyrRS + tetrazolyl phenylalanine
- 2zp1 – MjTyrRS (mutant) + Tyr
- 1zh0 - MjTyrRS (mutant) + naphthyl-Ala
- 1zh6, 2ag6, 4pbr - MjTyrRS (mutant) + Phe derivative
- 4hjx - MjTyrRS (mutant) + di-fluoro-Tyr
- 4nx2 - MjTyrRS (mutant) + di-chloro-Tyr
- 4hpw - MjTyrRS (mutant) + methyl-Tyr
- 5n5u - MjTyrRS + borono-Phe + AMP
- 2yxn – EcTyrRS residues 1-322 + azido-Tyr
- 1vbm – EcTyrRS + Tyr-SA
- 1vbn – EcTyrRS (mutant) + Tyr-SA
- 1x8x – EcTyrRS + Tyr
- 1wq3, 1wq4 - EcTyrRS (mutant) + Tyr
- 6wn2, 6wrn, 6wrt - EcTyrRS (mutant) + Tyr derivative
- 4oud - EcTyrRS + bi-Phe
- 6i5y - EcTyrRS + Tyr-SA
- 6hb5 - EcTyrRS + Tyr-SC
- 6hb6, 6hb7 - EcTyrRS + Tyr-SU
- 7ap3 - EcTyrRS + inhibitor
- 2j5b – TyrRS residues 2-346 + Tyr-ol – Acanthamoeba polyphaga minivirus
- 2cyb – AfTyrRS + Tyr - Archaeoglobus fulgidus
- 2cyc – PhTyrRS + Tyr
- 1h3f- TtTyrRS + Tyr-ol
- 1jii, 1jij, 1jil, 1jik – SaTyrRS + inhibitor
- 6otj – NgTyrRS + Tyr
- 1q11 – hTyrRS residues 1-364 + Tyr-ol
- Tyr-RS + tRNA
- 3-nitroTyr-RS
- Val-RS
- Class II aaRS
- Ala-RS
- Ala-RS + small substrates or analogs
- 5v59 - hAlaRS + AZ-SA
- 3hxu, 3hxv, 3hxw – EcAlaRS catalytic fragment + aa-adenylate
- 3hxz, 3hy0, 3hy1 - EcAlaRS catalytic fragment (mutant) + aa-adenylate
- 3hxx - EcAlaRS catalytic fragment + AMPPCP
- 3hxy - EcAlaRS catalytic fragment + AMPPCP + Ala-AMP + PCP
- 3htz - AaAlaRS residues 2-454 + Ser
- 1yfr – AaAlaRS + ATP
- 1yfs – AaAlaRS + Ala
- 1yft, 1ygb - AaAlaRS catalytic fragment + aa
- 2zzg - PhAlaRS + Ala-SA
- 2ztg– AfAlaRS + Ala-SA
- 5v59 - hAlaRS + AZ-SA
- Ala-RS + tRNA
- Asp-RS
- Asp-RS + small substrates or analogs
- Asp-RS + tRNA
- Asp-RS complex
- 5y6l - hAspRS + MetRS + Glu/ProRS + P18 + P38
- 6iy6 - hAspRS + AIMP2 + Glu/ProRS residues 1-157
- 1il2, 1c0a – EcAspRS + Asp-tRNA + Asp-adenylate
- 7ap4 – TtAspRS + inhibitor
- 6hhv, 6hhw – TtAspRS + Asp-SU
- 6hhx – TtAspRS + Asp-SC
- 6sjc – TtAspRS + Asp-SA
- 4wj4 – PaAspRS + Asn-tRNA + Asp
- 4wj3 – PaAspRS + Asn-tRNA + amidotransferase
- 5y6l - hAspRS + MetRS + Glu/ProRS + P18 + P38
- Asn-RS
- Asn-RS + small substrates or analogs
- Gly-RS
- Gly-RS + small substrates or analogs
- Gly-RS + tRNA
- His-RS
- His-RS + small substrates or analogs
- 4phc - hHisRS + His
- 3lc0 – TcHisRS residues 45-478 + His – Trypanosoma cruzi
- 4yp0, 4ypf, 4yrc, 4yrr, 4yrs - TcHisRS + quinoline derivative
- 4yre, 4yrj, 4yrk, 4yrp - TcHisRS + phenyl derivative
- 4yrg, 4yrm, 4yrn, 4yro - TcHisRS + pyridine derivative
- 4yrl - TcHisRS + aniline derivative
- 4yrq - TcHisRS + chromenone derivative
- 4yrt - TcHisRS + naphthalene derivative
- 4rdx – TtHisRS + tRNA
- 1adj – TtHisRS + His
- 3hrk - TbHisRS + His-adenylate
- 2el9 - EcHisRS + His-SA
- 1kmm, 1ady]] - EcHisRS + His-adenylate
- 1kmn - EcHisRS + His-ol + ATP
- 5e3i - AbHisRS + His + ATP
- 4e51 - BtHisRS + His
- 4phc - hHisRS + His
- Phe-RS
- Phe-RS + small substrates or analogs
- 3hfv – hPheRS + Tyr
- 3teg – hPheRS + L-DOPA
- 3pco – EcPheRS + phenylalanine+ AMP
- 6oz5, 6p26 – EcPheRS α+β chains + inhibitor
- 3hfz, 2amc – TtPheRS α+β chains + Tyr
- 2akw, 1b70 - TtPheRS α+β chains + Phe
- 4tva - TtPheRS α+β chains + Phe + puromycin
- 3teh - TtPheRS α+β chains + L-DOPA
- 1jjc, 1b7y - TtPheRS α+β chains + Phe-adenylate
- 2aly - TtPheRS α+β chains + Phe-SA
- 2rhq, 2rhs – PheRS α+β+ chains (mutant) + inhibitor – Staphylococcus haemolyticus
- 4p72, 4p73, 4p74, 4p75 – PaPheRS α+β chains + inhibitor
- 7db7, 7db8 – MtPheRS α+β chains + inhibitor
- 6p8t – AbPheRS α+β chains + inhibitor
- 3hfv – hPheRS + Tyr
- Phe-RS + tRNA
- Pro-RS
- Pro-RS + small substrates or analogs
- Pro-RS ternary complex
- 4k87 – hProRS residues 1000-1512 + proline + adenosine
- 4k88 – hProRS residues 1000-1512 + halofunginone
- 1h4q - TtProRS + Pro-tRNA + Pro-ol
- 1h4s - TtProRS + Pro-tRNA + Pro-SA
- 2j3m – EfProRS + Pro-ol + ATP
- 5f9z – CpProRS residues 186-688 + halofuginone + AMPPNP
- 5f9y – CpProRS residues 186-688 + proline + AMP
- 5xio – CpProRS residues 225-719 + halofuginone + ANP
- 5znj – SaProRS + halofuginone + ANP
- 5znk – SaProRS + inhibitor + ANP
- 6nab - NfProRS + Pro + AMP – Naegleria fowleri
- 6uyh – NfProRS + halofuginone + ANP
- 5xiq – TgProRS residues 334-830 + halofuginone + ANP
- 5xik, 6a88 – TgProRS residues 334-830 + febrifugine derivative + ANP
- 5xig, 5xih, 5xij – TgProRS residues 334-830 + inhibitor + ANP
- 5xii – TgProRS residues 334-830 (mutant) + inhibitor + ANP
- 4ydq, 4q15, 4olf – PfProRS residues 254-746 + halofuginone + AMPPNP
- 6t7k – PfProRS residues 254-746 + inhibitor
- 4k87 – hProRS residues 1000-1512 + proline + adenosine
- Bifunctional RS (bifunctional glutamate/proline tRNA ligase)
- Pyrrolysyl-RS; domains – RNA-binding 1-101; catalytic 188-454
- Pyrrolysyl-RS binary complex
- 3qtc – MmPylRS catalytic domain (mutant) + AMP-ATP analog
- 2q7e - MmPylRS catalytic domain + ATP analog
- 3vqv - MmPylRS catalytic domain + AMPPNP
- 4bw9, 4cs4, 5k1p, 5k1x - MmPylRS catalytic domain (mutant) + AMPPNP
- 4bwa - MmPylRS catalytic domain (mutant) + adenylated norbornene
- 4ch3, 4ch4, 4ch5, 4ch6 - MmPylRS catalytic domain + adenylated lysine derivative
- 4cs3 - MmPylRS catalytic domain (mutant) + adenylated lysine derivative
- 5ud5 - MmPylRS RNA-binding domain + Pyl-RNA
- 5v6x - MmPylRS RNA-binding domain (mutant) + Pyl-RNA
- 2zni, 2znj – DhLysRS + tRNA
- 3qtc – MmPylRS catalytic domain (mutant) + AMP-ATP analog
- Pyrrolysyl-RS ternary complex
- 2zce - MmPylRS catalytic domain + pyrrolysine + ATP analog
- 2q7g - MmPylRS catalytic domain + pyrrolysine analog + ATP
- 2zim, 2q7h - MmPylRS catalytic domain + adenylated pyrrolysine + pyrophosphate
- 2zio - MmPylRS catalytic domain + AlocLys-AMP + ATP analog
- 3vqy - MmPylRS catalytic domain + butoxycarbonyl lysine + AMPPNP
- 4q6g - MmPylRS catalytic domain + acetyl lysine + ADPNP
- 4tqd - MmPylRS catalytic domain + iodo-Phe + ATP
- 4tqf, 4zib - MmPylRS catalytic domain + bromothienylo-Ala + ATP
- 6ly3, 6ly6, 6lyb - MmPylRS catalytic domain (mutant) + Ala derivative+ ANP
- 6ly7, 6lya - MmPylRS catalytic domain (mutant) + Trp derivative + ANP
- 2zin - MmPylRS catalytic domain + butoxycarbonyl lysine + ATP analog
- 6aac, 6aad, 6aao, 6aap, 6aaz, 6ab0, 6ab1, 6ab2, 6ab8, 6abk, 6abl, 6abm, 6aan, 6anq - MmPylRS catalytic domain + azanyl derivative + ATP
- 2zce - MmPylRS catalytic domain + pyrrolysine + ATP analog
- Ser-RS
- Ser-RS + small substrates or analogs
- 4l87 - hSerRS + Ser-SA
- 1wle – bSerRS + Ser-adenylate - bovine
- 2zr2 – PhSerRS + ATP
- 2dq0 – PhSerRS + Ser-SA
- 2cj9 – MbSerRS + Ser-SA
- 2cjb – MbSerRS + Ser
- 2cja – MbSerRS + ATP
- 1ses, 1set – TtSerRS + Ser-adenylate analog
- 6r1m, 6r1n – SaSerRS + Ser-SA
- 6hdz, 6he1, 6hhy, 6hi0 – PaSerRS + Ser-SU
- 6he3, 6hhz – PaSerRS + Ser-SC
- 6r1o – EcSerRS + Ser-SA
- 6h9x – KpSerRS + Ser-SA
- 7ap1 – KpSerRS + inhibitor
- 6ote – CpSerRS + Ser-SA
- 6x94 – MmSerRS + Ser-SA
- 4l87 - hSerRS + Ser-SA
- Ser-RS + tRNA
- PhosphoSer-RS
- Thr-RS
- Thr-RS + small substrates or analogs
- 4p3n - hThrRS editing domain 322-723 + borrelidin
- 4hws - hThrRS editing domain + inhibitor
- 3uh0 - yThrRS editing domain + Thr-SA
- 4eo4 - yThrRS editing domain + Ser-SA
- 3pd2, 3pd3, 3pd4, 3pd5 – PabThrRS editing domain + aa-aminoadenosine
- 2hkz – PabThrRS editing domain + Ser
- 2hl0, 2hl1 - PabThrRS editing domain + Ser-adenylate
- 2hl2 - PabThrRS editing domain + Ser-SA
- 1tke - EcThrRS editing domain + Ser
- 1tkg - EcThrRS editing domain + Ser-SA
- 1tky - EcThrRS editing domain + Ser-adenylate
- 4p3o, 4p3p - EcThrRS editing domain + borrelidin
- 4hwo, 4hwp, 4hwr, 4hws - EcThrRS editing domain + inhibitor
- 1fyf, 1evl - EcThrRS catalytic and anticodon-binding domains + aa-SA
- 1evk - EcThrRS catalytic and anticodon-binding domains + Thr
- 1nyq – SaThrRS + Thr-SA
- 1nyr – SaThrRS + ATP
- 4s02, 4s03, 4s0i, 4s0j, 4s0k, 4s0l - PabThrRS (mutant) + bi-Phe
- 4rrq - PabThrRS editing domain + Ser
- 4rrr - PabThrRS editing domain + Thr
- 4rrf - MjThrRS editing domain + Ser
- 4rrg - MjThrRS editing domain + Thr
- 6l2q - ThrRS 222-622 + inhibitor – Salmonella enterica
- 4p3n - hThrRS editing domain 322-723 + borrelidin
- Thr-RS + tRNA
}}